Patrizia Bernuzzi

924 total citations
21 papers, 524 citations indexed

About

Patrizia Bernuzzi is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Patrizia Bernuzzi has authored 21 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 7 papers in Genetics. Recurrent topics in Patrizia Bernuzzi's work include Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Patrizia Bernuzzi is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Patrizia Bernuzzi collaborates with scholars based in Italy, Ukraine and France. Patrizia Bernuzzi's co-authors include Luigi Cavanna, Daniele Vallisa, Carlo Moroni, Antonio Lazzaro, Mario Lazzarino, Raffaella Bertè, Elisa Anselmi, Luca Arcaini, Elena Trabacchi and Roberto Marasca and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Patrizia Bernuzzi

20 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrizia Bernuzzi Italy 11 249 221 206 156 101 21 524
Kayoko Murayama Japan 12 277 1.1× 230 1.0× 133 0.6× 76 0.5× 70 0.7× 39 489
Elisa Anselmi Italy 10 131 0.5× 219 1.0× 106 0.5× 130 0.8× 98 1.0× 30 496
Miriam Tao Singapore 16 477 1.9× 479 2.2× 135 0.7× 173 1.1× 236 2.3× 58 941
Ying-Chung Hong Taiwan 10 131 0.5× 134 0.6× 49 0.2× 202 1.3× 265 2.6× 20 534
Livio Gargantini Italy 19 563 2.3× 396 1.8× 311 1.5× 72 0.5× 74 0.7× 31 1.1k
Liang‐Tsai Hsiao Taiwan 12 118 0.5× 112 0.5× 114 0.6× 23 0.1× 81 0.8× 50 477
Olga Trejo Spain 12 88 0.4× 49 0.2× 123 0.6× 332 2.1× 212 2.1× 17 839
C. Antoine France 8 150 0.6× 248 1.1× 49 0.2× 28 0.2× 99 1.0× 18 434
Catello Califano Italy 16 102 0.4× 211 1.0× 153 0.7× 69 0.4× 66 0.7× 25 652
J.P. Laporte France 12 171 0.7× 207 0.9× 94 0.5× 19 0.1× 61 0.6× 32 574

Countries citing papers authored by Patrizia Bernuzzi

Since Specialization
Citations

This map shows the geographic impact of Patrizia Bernuzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrizia Bernuzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrizia Bernuzzi more than expected).

Fields of papers citing papers by Patrizia Bernuzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrizia Bernuzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrizia Bernuzzi. The network helps show where Patrizia Bernuzzi may publish in the future.

Co-authorship network of co-authors of Patrizia Bernuzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Patrizia Bernuzzi. A scholar is included among the top collaborators of Patrizia Bernuzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrizia Bernuzzi. Patrizia Bernuzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavanna, Luigi, Livia Ruffini, Emanuele Michieletti, et al.. (2023). Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature. Medicina. 59(1). 157–157. 13 indexed citations
2.
Matteis, Serena De, Beatrice Casadei, Francesco Barbato, et al.. (2022). Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy. Frontiers in Immunology. 13. 994731–994731. 1 indexed citations
3.
Cavanna, Luigi, Chiara Citterio, Claudia Biasini, et al.. (2021). COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy. European Journal of Cancer. 157. 441–449. 36 indexed citations
4.
Taliani, Gloria, Lorenzo Guglielmetti, Patrizia Bernuzzi, et al.. (2021). Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure. Frontiers in Oncology. 10. 582901–582901. 3 indexed citations
5.
Arcari, Annalisa, Annalisa Chiappella, Michele Spina, et al.. (2015). Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study. Leukemia & lymphoma. 57(8). 1823–1830. 22 indexed citations
6.
7.
Belloni, Elena, Daniela Aschieri, Patrizia Bernuzzi, et al.. (2012). Inversion time prolongation at late enhancement cardiac magnetic resonance in a myeloma patient. Diagnostic and Interventional Radiology. 18(6). 552–4. 1 indexed citations
8.
Vallisa, Daniele, Massimo Piepoli, Luigi Cavanna, et al.. (2007). Autologous Bone-Marrow Stem Cell Support in Acute Anterior Myocardial Infarction.. Blood. 110(11). 3692–3692. 2 indexed citations
9.
Arcari, Annalisa, Elisa Anselmi, Patrizia Bernuzzi, et al.. (2005). Primary pancreatic lymphoma. Report of five cases.. PubMed. 90(2). ECR09–ECR09. 30 indexed citations
10.
Arcari, Annalisa, Elisa Anselmi, Patrizia Bernuzzi, et al.. (2005). Primary pancreatic lymphoma. A report of five cases.. PubMed. 90(1). ECR09–ECR09. 9 indexed citations
11.
Anselmi, Elisa, Annalisa Arcari, Patrizia Bernuzzi, et al.. (2005). [Thrombotic thrombocytopenic purpura: report of seven cases].. PubMed. 20(2). 108–12.
12.
Lazzaro, Antonio, Patrizia Bernuzzi, Elena Trabacchi, et al.. (2005). Imatinib-Related Neutropenia in Chronic-Phase Chronic Myelogenous Leukaemia: Safety and Efficacy of Granulocyte-Colony-Stimulating Factor (Filgrastim) Use.. Blood. 106(11). 4864–4864. 2 indexed citations
13.
Vallisa, Daniele, Patrizia Bernuzzi, Luca Arcaini, et al.. (2005). Role of Anti-Hepatitis C Virus (HCV) Treatment in HCV-Related, Low-Grade, B-Cell, Non-Hodgkin's Lymphoma: A Multicenter Italian Experience. Journal of Clinical Oncology. 23(3). 468–473. 191 indexed citations
14.
Morra, Enrica, Clara Cesana, Catherine Klersy, et al.. (2004). Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders. Leukemia. 18(9). 1512–1517. 33 indexed citations
15.
Cavanna, Luigi, Alberto Zaniboni, Fabrizio Artioli, et al.. (2004). Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC). Journal of Clinical Oncology. 22(14_suppl). 4068–4068. 5 indexed citations
16.
Imberti, Davide, Daniele Vallisa, Elisa Anselmi, et al.. (2004). Safety and Efficacy of Enoxaparin Treatment in Venous Thromboembolic Disease during Acute Leukemia. Tumori Journal. 90(4). 390–393. 29 indexed citations
17.
18.
Cesana, Clara, Sara Miqueleiz, Patrizia Bernuzzi, et al.. (2003). Smouldering Waldenstrom's macroglobulinemia: Factors predicting evolution to symptomatic disease. Seminars in Oncology. 30(2). 231–235. 12 indexed citations
19.
Nosari, Annamaria, Patrizia Bernuzzi, Ester Pungolino, et al.. (2002). Late Response to Cyclosporine in Refractory Thrombotic Thrombocytopenic Purpura. International Journal of Hematology. 76(3). 284–286. 7 indexed citations
20.
Morra, Enrica, Livio Gargantini, Annamaria Nosari, et al.. (2000). Treatment of patients with high-grade non-Hodgkin’s lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators. Critical Reviews in Oncology/Hematology. 35(2). 95–100. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayoko Murayama Breakdown of academic impact, for papers by Elisa Anselmi Breakdown of academic impact, for papers by Miriam Tao Breakdown of academic impact, for papers by Ying-Chung Hong Breakdown of academic impact, for papers by Livio Gargantini Breakdown of academic impact, for papers by Liang‐Tsai Hsiao Breakdown of academic impact, for papers by Olga Trejo Breakdown of academic impact, for papers by C. Antoine Breakdown of academic impact, for papers by Catello Califano Breakdown of academic impact, for papers by J.P. Laporte
Rankless by CCL
2026